Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial

Linda O'Neill, Emer Guinan, Suzanne Doyle, Deirdre Connolly, Jacintha O'Sullivan, Annemarie Bennett, Grainne Sheill, Ricardo Segurado, Peter Knapp, Ciaran Fairman, Charles Normand, Justin Geoghegan, Kevin Conlon, John V Reynolds, Juliette Hussey, Linda O'Neill, Emer Guinan, Suzanne Doyle, Deirdre Connolly, Jacintha O'Sullivan, Annemarie Bennett, Grainne Sheill, Ricardo Segurado, Peter Knapp, Ciaran Fairman, Charles Normand, Justin Geoghegan, Kevin Conlon, John V Reynolds, Juliette Hussey

Abstract

Background: Curative treatment for upper gastrointestinal (UGI) and hepatopancreaticobiliary (HPB) cancers, involves complex surgical resection often in combination with neoadjuvant/adjuvant chemo/chemoradiotherapy. With advancing survival rates, there is an emergent cohort of UGI and HPB cancer survivors with physical and nutritional deficits, resultant from both the cancer and its treatments. Therefore, rehabilitation to counteract these impairments is required to maximise health related quality of life (HRQOL) in survivorship. The initial feasibility of a multidisciplinary rehabilitation programme for UGI survivors was established in the Rehabilitation Strategies following Oesophago-gastric Cancer (ReStOre) feasibility study and pilot randomised controlled trial (RCT). ReStOre II will now further investigate the efficacy of that programme as it applies to a wider cohort of UGI and HPB cancer survivors, namely survivors of cancer of the oesophagus, stomach, pancreas, and liver.

Methods: The ReStOre II RCT will compare a 12-week multidisciplinary rehabilitation programme of supervised and self-managed exercise, dietary counselling, and education to standard survivorship care in a cohort of UGI and HPB cancer survivors who are > 3-months post-oesophagectomy/ gastrectomy/ pancreaticoduodenectomy, or major liver resection. One hundred twenty participants (60 per study arm) will be recruited to establish a mean increase in the primary outcome (cardiorespiratory fitness) of 3.5 ml/min/kg with 90% power, 5% significance allowing for 20% drop out. Study outcomes of physical function, body composition, nutritional status, HRQOL, and fatigue will be measured at baseline (T0), post-intervention (T1), and 3-months follow-up (T2). At 1-year follow-up (T3), HRQOL alone will be measured. The impact of ReStOre II on well-being will be examined qualitatively with focus groups/interviews (T1, T2). Bio-samples will be collected from T0-T2 to establish a national UGI and HPB cancer survivorship biobank. The cost effectiveness of ReStOre II will also be analysed.

Discussion: This RCT will investigate the efficacy of a 12-week multidisciplinary rehabilitation programme for survivors of UGI and HPB cancer compared to standard survivorship care. If effective, ReStOre II will provide an exemplar model of rehabilitation for UGI and HPB cancer survivors.

Trial registration: The study is registered with ClinicalTrials.gov, registration number: NCT03958019, date registered: 21/05/2019.

Keywords: Diet; Exercise; Hepatobiliary cancer; Liver cancer; Multidisciplinary rehabilitation; Oesophagogastric cancer; Pancreatic cancer.

Conflict of interest statement

Dr. Emer Guinan is a member of the editorial board (Associate Editor) of this journal. Other authors have no competing interests to disclose.

Figures

Fig. 1
Fig. 1
Participant flow through study

References

    1. Clauss D, Tjaden C, Hackert T, Schneider L, Ulrich CM, Wiskemann J, et al. Cardiorespiratory fitness and muscle strength in pancreatic cancer patients. Support Care Cancer. 2017;25(9):2797–2807. doi: 10.1007/s00520-017-3694-8.
    1. O'Neill L, Moran J, Guinan EM, Reynolds JV, Hussey J. Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review. J Cancer Surviv. 2018;12(4):601–18.
    1. Heneghan HM, Zaborowski A, Fanning M, McHugh A, Doyle S, Moore J, et al. Prospective study of Malabsorption and malnutrition after esophageal and gastric Cancer surgery. Ann Surg. 2015;262(5):803–807. doi: 10.1097/SLA.0000000000001445.
    1. Clancy TE. Surgery for pancreatic Cancer. Hematol Oncol Clin North Am. 2015;29(4):701–716. doi: 10.1016/j.hoc.2015.04.001.
    1. Wolf MC, Stahl M, Krause BJ, Bonavina L, Bruns C, Belka C, et al. Curative treatment of oesophageal carcinoma: current options and future developments. Radiat Oncol. 2011;6(1):55. doi: 10.1186/1748-717X-6-55.
    1. Chedid MF, Kruel CRP, Pinto MA, Grezzana-Filho TJM, Leipnitz I, Kruel CDP, et al. Hepatocellular carcinoma: diagnosis and operative management. Arq Bras Cir Dig. 2017;30(4):272–278. doi: 10.1590/0102-6720201700040011.
    1. Shilpa J, Paulose CS. GABA and 5-HT chitosan nanoparticles decrease striatal neuronal degeneration and motor deficits during liver injury. J Mater Sci Mater Med. 2014;25(7):1721–1735. doi: 10.1007/s10856-014-5195-3.
    1. Martin L, Lagergren P. Long-term weight change after oesophageal cancer surgery. Br J Surg. 2009;96(11):1308–1314. doi: 10.1002/bjs.6723.
    1. Reynolds J, Preston S, O’Neill B, Baeksgaard L, Griffin S, Mariette C, et al. ICORG 10-14: NEOadjuvant trial in adenocarcinoma of the oEsophagus and oesophagoGastric junction international study (neo-AEGIS) BMC Cancer. 2017;17(1):401. doi: 10.1186/s12885-017-3386-2.
    1. Shubert CR, Bergquist JR, Groeschl RT, Habermann EB, Wilson PM, Truty MJ, et al. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: an intention to treat analysis of the National Cancer Database. Surgery. 2016;160(4):1080–1096. doi: 10.1016/j.surg.2016.06.010.
    1. Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P, et al. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer. Ann Surg. 2017;266:822–830. doi: 10.1097/SLA.0000000000002398.
    1. Hashimoto D, Chikamoto A, Ohmuraya M, Abe S, Nakagawa S, Beppu T, et al. Impact of postoperative weight loss on survival after resection for pancreatic Cancer. JPEN J Parenter Enteral Nutr. 2015;39(5):598–603. doi: 10.1177/0148607114520992.
    1. Gannon J, Guinan E, Doyle SL, Beddy P, Reynolds J, Hussey J. Reduced fitness and physical functioning are long-term sequalae after curative treatment for esophageal cancer; a matched control study diseases of the esophagus. 2017.
    1. Donohoe CL, McGillycuddy E, Reynolds JV. Long-term health-related quality of life for disease-free esophageal cancer patients. World J Surg. 2011;35(8):1853–1860. doi: 10.1007/s00268-011-1123-6.
    1. Chen L, Liu Y, Li GG, Tao SF, Xu Y, Tian H. Quality of life in patients with liver cancer after operation: a 2-year follow-up study. Hepatobiliary Pancreat Dis Int. 2004;3(4):530–533.
    1. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–1426. doi: 10.1249/MSS.0b013e3181e0c112.
    1. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for Cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390. doi: 10.1249/MSS.0000000000002116.
    1. Pekmezi DW, Demark-Wahnefried W. Updated Evidence in Support of Diet and Exercise Interventions in Cancer Survivors. Acta oncologica (Stockholm, Sweden) 2011;50(2):167–178. doi: 10.3109/0284186X.2010.529822.
    1. Arthur AE, Delk A, Demark-Wahnefried W, Christein JD, Contreras C, Posey JA, et al. Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventions. J Cancer Surviv. 2016;10(6):981–989. doi: 10.1007/s11764-016-0544-5.
    1. Guinan EM, Doyle SL, O'Neill L, Dunne MR, Foley EK, O'Sullivan J, et al. Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study. Support Care Cancer. 2017;25(3):749–756. doi: 10.1007/s00520-016-3455-0.
    1. O'Neill L, Guinan E, Doyle S, Elliot J, O'Sullivan J, Reynolds JV, et al. Rehabilitation strategies following esophageal cancer (the ReStOre trial); a feasibility study. Dis Esophagus. 2017;30(5):1–8. doi: 10.1093/dote/dow012.
    1. O'Neill LM, Guinan E, Doyle SL, Bennett AE, Murphy C, Elliott JA, et al. The RESTORE randomized controlled trial: impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in Esophagogastric cancer survivorship. Ann Surg. 2018;268(5):747–755. doi: 10.1097/SLA.0000000000002895.
    1. Bennett AE, O’Neill L, Connolly D, Guinan EM, Boland L, Doyle SL, et al. Patient experiences of a physiotherapy-led multidisciplinary rehabilitative intervention after successful treatment for oesophago-gastric cancer. Support Care Cancer. 2018.
    1. Healthy Ireland, Department of Health, Office NPS. National Cancer Strategy 2017-2026. Ireland: Department of Health; 2017.
    1. Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35(3):307–315.
    1. Williams N. The Borg rating of perceived exertion (RPE) scale. Occup Med. 2017;67(5):404–405. doi: 10.1093/occmed/kqx063.
    1. American College of Sports Medicine position stand Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41(3):687–708. doi: 10.1249/MSS.0b013e3181915670.
    1. Fairman CM, Nilsen TS, Newton RU, Taaffe DR, Spry N, Joseph D, et al. Reporting of resistance training dose, adherence, and tolerance in exercise oncology. Med Sci Sports Exerc. 2020;52(2):315–322. doi: 10.1249/MSS.0000000000002127.
    1. Fairman CM, Kendall KL, Newton RU, Hart NH, Taaffe DR, Chee R, et al. Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial. BMJ Open. 2019;9(9):e030080–e03008e. doi: 10.1136/bmjopen-2019-030080.
    1. Guinan EM, Doyle S, O'Neill L, O'Sullivan J, Reynolds PJV, Hussey JM, et al. J Clin Oncol. 2016;34(3_suppl):176. doi: 10.1200/jco.2016.34.3_suppl.176.
    1. World Cancer Research Fund/ American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018. Available at .
    1. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr (Edinburgh, Scotland) 2017;36(1):11–48. doi: 10.1016/j.clnu.2016.07.015.
    1. Myers J, McAuley P, Lavie CJ, Despres JP, Arena R, Kokkinos P. Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Prog Cardiovasc Dis. 2015;57(4):306–314. doi: 10.1016/j.pcad.2014.09.011.
    1. Agnew N. Preoperative cardiopulmonary exercise testing. Continuing Educ Anaesth Crit Care Pain. 2010;10(2):33–37. doi: 10.1093/bjaceaccp/mkq001.
    1. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–M94. doi: 10.1093/geronj/49.2.M85.
    1. ACSM . ACSM's guidelines for exercise testing and prescription. 8th ed. Thompson WR, editor. Philadelphia: Lippincott Williams & Wilkins; 2010.
    1. Forrest KYZ, Williams AM, Leeds MJ, Robare JF, Bechard TJ. Patterns and correlates of grip strength in older Americans. Current aging science. 2018;11(1):63–70. doi: 10.2174/1874609810666171116164000.
    1. Broderick JM, Ryan J, O’Donnell DM, Hussey J. A guide to assessing physical activity using accelerometry in cancer patients. Support Care Cancer. 2014;22(4):1121–1130. doi: 10.1007/s00520-013-2102-2.
    1. Guinan EM, Bennett AE, Doyle SL, O’Neill L, Gannon J, Foley G, et al. Measuring the impact of oesophagectomy on physical functioning and physical activity participation: a prospective study. BMC Cancer. 2019;19(1):682. doi: 10.1186/s12885-019-5888-6.
    1. Timon CM, Blain RJ, McNulty B, Kehoe L, Evans K, Walton J, et al. The development, validation, and user evaluation of Foodbook24: a web-based dietary assessment tool developed for the Irish adult population. J Med Internet Res. 2017;19(5):e158. doi: 10.2196/jmir.6407.
    1. Svedlund J, Sjodin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129–134. doi: 10.1007/BF01535722.
    1. Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–1081. doi: 10.1093/ajcn/82.5.1074.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365.
    1. Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–325. doi: 10.1016/0022-3999(94)00125-O.
    1. Nilsen TS, Scott JM, Michalski M, Capaci C, Thomas S, Herndon JE, 2nd, et al. Novel methods for reporting of exercise dose and adherence: an exploratory analysis. Med Sci Sports Exerc. 2018;50(6):1134–1141. doi: 10.1249/MSS.0000000000001545.
    1. Sheill G, Guinan E, O’Neill L, Normand C, Doyle SL, Moore S, et al. Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PRE-HIIT): protocol for a randomized controlled trial. BMC Cancer. 2020;20(1):321. doi: 10.1186/s12885-020-06795-4.
    1. Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist. 2011;16(1):112–120. doi: 10.1634/theoncologist.2010-0197.
    1. Neergaard MA, Olesen F, Andersen RS, Sondergaard J. Qualitative description – the poor cousin of health research? BMC Med Res Methodol. 2009;9(1):52. doi: 10.1186/1471-2288-9-52.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi: 10.1191/1478088706qp063oa.
    1. Crocker JC, Ricci-Cabello I, Parker A, Hirst JA, Chant A, Petit-Zeman S, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ. 2018;363:k4738. doi: 10.1136/bmj.k4738.
    1. Treweek S, Bevan S, Bower P, Campbell M, Christie J, Clarke M, et al. Trial forge guidance 1: what is a study within a trial (SWAT)? Trials. 2018;19(1):139. doi: 10.1186/s13063-018-2535-5.
    1. Knapp P, Raynor DK, Silcock J, Parkinson B. Can user testing of a clinical trial patient information sheet make it fit-for-purpose? - a randomized controlled trial. BMC Med. 2011;9(1):89. doi: 10.1186/1741-7015-9-89.
    1. Knapp P, Raynor DK, Silcock J, Parkinson B. Performance-based readability testing of participant materials for a phase I trial: TGN1412. J Med Ethics. 2009;35(9):573–578. doi: 10.1136/jme.2008.026708.
    1. O'Neill L, Knapp P, Doyle S, Guinan E, Parker A, Segurado R, et al. Patient and family co-developed participant information to improve recruitment rates, retention, and patient understanding in the rehabilitation strategies following Oesophago-gastric and Hepatopancreaticobiliary Cancer (ReStOre II) trial: protocol for a study within a trial (SWAT). HRB Open Res. 2019.
    1. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801. doi: 10.1056/NEJMoa011858.
    1. Gulati M, Pandey DK, Arnsdorf MF, Lauderdale DS, Thisted RA, Wicklund RH, et al. Exercise capacity and the risk of death in women. Circulation. 2003;108(13):1554. doi: 10.1161/01.CIR.0000091080.57509.E9.
    1. Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 2012;76(2):248–252. doi: 10.1016/j.lungcan.2011.10.009.
    1. Moran J, Wilson F, Guinan E, McCormick P, Hussey J, Moriarty J. Role of cardiopulmonary exercise testing as a risk-assessment method in patients undergoing intra-abdominal surgery: a systematic review. Br J Anaesth. 2016;116(2):177–191. doi: 10.1093/bja/aev454.
    1. Peel JB, Sui X, Matthews CE, Adams SA, Hebert JR, Hardin JW, et al. Cardiorespiratory fitness and digestive cancer mortality: findings from the aerobics center longitudinal study. Cancer Epidemiol Biomark Prev. 2009;18(4):1111–1117. doi: 10.1158/1055-9965.EPI-08-0846.
    1. Peel JB, Sui X, Adams SA, Hebert JR, Hardin JW, Blair SN. A prospective study of cardiorespiratory fitness and breast cancer mortality. Med Sci Sports Exerc. 2009;41(4):742–748. doi: 10.1249/MSS.0b013e31818edac7.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅